The antigen receptor that is present on the surface of most T cells is a heterodimer composed of disulfide-linked ct and S chains, each of which has C and V regions (see reference 1 for a review). The V region of each fl chain is encoded by noncontiguous variable (Vg), diversity (DO), and joining Up) gene segments that are juxtaposed during T cell development by the process of somatic rearrangement. To date, only 22 murine TCR /3 chain V region (Vg) gene segments (20 functional genes and two VS pseudogenes) have been identified, largely from analysis of Cp" clones from cDNA libraries (1) (2) (3) . A statistical analysis of the first 25 Vp sequences identified (representing 14 independent Vp gene segments) yielded a maximum likelihood estimate of 18 for the maximum number of Vp genes, with a 95% one-sided confidence bound of 30 (4) . This estimate, however, is based on the assumption that each of the Vp genes is equally likely to be used, whereas actual gene usage may be nonrandom. In fact, the actual Vp repertoire is affected by at least two mechanisms, deletion and nonexpression. Examples of gene deletion are the Vs haplotype strains of mice, such as SJL, SWR, C57BR, C57L, and AU/SsJ, which have a deletion within the Vp locus that eliminates 10 contiguous Vp gene segments (5) (6) (7) . Examples of the nonexpression of a Vp gene are the instances of clonal elimination of T cells bearing a/(3 receptors that are reactive to so-called "superantigens" in combination with certain H-2 class II molecules (8) (9) (10) (11) (12) (13) (14) .
If, in fact, Vp gene usage is nonrandom, then there may exist many Vp genes that are used at low frequency and have not been isolated from cDNA libraries. However, only one complete new functional Vp gene, Vp17a (15) , has been identified in the last 3 yr. Isolation of another Vp gene, provisionally called Vp18, has been reported, but only a partial nucleotide sequence of this gene has been published (16) . We sought to investigate whether there exist yet-undiscovered Vp genes that are expressed at low frequency and whether there exists a substantial number of pseudogenes by using a panel of cosmid clones, spanning the BALB/c Vp gene locus, that had been previously isolated in our laboratory (6) .
In this paper, we report a novel method for identifying new Vp genes and present details on seven new Vp genes. The new method involves probing cloned genomic DNA with a VS-specific oligonucleotide instead of screening cDNA with a Cs-specific probe, thereby circumventing the problem, encountered with screening cDNA, of low expression of certain functional Vo genes. We report here the discovery of a new functional V0 gene, V019a, and six pseudogenes, including VS19b, as well as further studies on the expression of V019. In addition, we present the complete nucleotide sequence of BALB/c V018, which was isolated from cloned genomic DNA after probing with a cDNA probe.
Materials and Methods
Mice. 5-wk-old BALB/cJ, C57BL/6J, SJL/J, SWR/J, C57BR/cdj, and C57L/J mice were obtained from The Jackson Laboratory, Bar Harbor, ME.
Oligonuckotides. Oligonucleotides, which were used as hybridization probes, sequencing primers, and polymerase chain reaction (PCR)' primers, were synthesized on a DNA synthesizer (380A; Applied Biosystems, Inc., Foster City, CA) .
Screening of Cosmids with a VO-specific Oligonucleotide. The overlapping cosmid clones spanning 330 kb of the Vs locus in BALB/c, along with the restriction map, have been previously described (6) .
Cosmid DNA was digested with restriction endonucleases and separated on a0.7% agarose gel . The gel was dried, denatured in 0.5 N NaOH, 1.5 M NaCl, neutralized in 0.5 M Tris (pH 7.6), 0.75 M NaCl, and hybridized at 42°C with a Vs-specific oligonucleotide, called the CASS oligonucleotide (described in Results and shown in Fig. 1 ), that had been 5' end labeled with T4 polynucleotide kinase and .y-[32 p]ATP The hybridization solution consisted of 0.9 M NaCl, 0.18 M Tris (pH 7.4), 12 mM EDTA, 10 mM sodium pyrophosphate, and 2 x Denhardt's solution . After hybridization, gels were washed at room temperature with 5 x SSC (0.75 M NaCl, 0.075 M sodium citrate) and then exposed to film, with an intensifying screen, at -70°C .
Six CASS oligonucleotide-positive restriction fragments that did not contain previously reported Vs genes were identified (designated by an N, for new, followed by a number) and subcloned into pBluescribe (Stratagene, LaJolla, CA) to generate the corresponding plasmids (pNI, pN2, etc .).
DNA Sequencing The sequence ofpotential Vs genes in the subcloned CASS oligonucleotide-positive restriction fragments was determined by the chain-termination method (17) , as modified for sequencing double-stranded plasmid DNA with Sequenase DNA polymerase (United States Biochemical Corp., Cleveland, OH). Initial sequence data were obtained using the CASS oligonucleotide as sequencing primer; additional sequence data upstream, downstream, and on the opposite strand were obtained using sequencing primers derived from the initial sequence .
Vs18 had been previously localized on the genomic map (6) by hybridization of restricted cosmid DNA with a Vs18 cDNA probe provided by Dr. P A. Singer (Scripps Clinic and Research Foundation, LaJolla, CA) . For sequencing, a 4-kb Bam HI-Sal I fragment from cosmid C55 was subcloned into pBluescribe, and the nucleotide sequence of VO18 was obtained by the method of Maxam and Gilbert (18) .
Sequence analyses were performed using the Microgenie sequence analysis program (Beckman Instruments, Inc., Palo Alto, CA) .
RNase Protection. Total cellular RNA from spleen and thymus of 5-wk-old mice of six different strains was prepared by the guanidinium isothiocyanate method (19) .
RNA probes were synthesized according to the protocol from the supplier (Stratagene). Antisense V#16 RNA was synthesized from a DNA template that consisted of a genomic Xba I fragment containing 67 by of the intron between the first and second VO exons, 293 by of the second exon, and -220 by of 3' flanking region. Antisense Vs19 RNA was synthesized from a DNA template that consisted of a genomic Nhe I fragment containing 79 by ' Abbreviation used in this paper . PCR, polymenese chain reaction .
of leader exon and adjacent 5' untranslated region, 112 by of intron between the first and second Va exons, and 285 by of second exon .
RNase protection was performed according to the method of Melton et al . (20) , with minor modifications as detailed in Anderson et al. (21) .
Southern Blot Analysis. 15 l~g of high molecular weight DNA from BALB/c and SJL liver was digested with restriction endonucleases and separated on a 0.7% agarose gel. The gel was dried, denatured, and neutralized as described for the screening of cosmids, and then hybridized with a uniformly 32P-labeled probe generated by random hexanucleotide-primed synthesis by the Klenow fragment of Escherichia coli DNA polymerase I in the presence of a-["P]dCTP (22) .
The VgN3 probe was a 283-bp Nhe I-Nco I fragment from pN3, containing almost the entire second exon (which encodes a few amino acids of the leader peptide and all amino acids of the mature VS polypeptide segment) . The VON1 probe was a 410-bp Bsm I-Hpa I fragment from pNl, containing the entire second exon, -40 by of upstream intron, and -90 by of 3' flanking sequence .
Gels were hybridized at 65'C in 5 x SSC, 5 x Denhardt's solution, 10 mM sodium pyrophosphate, and 100 p,g/ml sheared, denatured salmon sperm DNA. After hybridization, gels were washed with 2 x SSC (0 .3 M NaCl, 0.03 M sodium citrate) at 65°C and then exposed to film, with an intensifying screen, at -70°C.
Cloning of Vg19 from SJL by the PCR. PCR was performed according to the protocol supplied by Perkin-Elmer Cetus (Norwalk, CT). 1 hg of high molecular weight DNA from SJL liver was subjected to 30 cycles of PCR in a total volume of 100 pl, containing 50 mM KCI, 10 mM Tris (pH 8.3), 1.5 MM MgC1 2, 1.5 mM of each dNTP, gelatin at 100 Icg/ml, N1 jug of each primer, and 5 U of Taq polymerase (Perkin-Elmer Cetus) . Except for the first cycle, which included a prolonged 5-min denaturation step, and the last cycle, which included a prolonged 5-min polymerization step, the intervening 28 PCR cycles consisted of denaturation at 90°C for 1.5 min, annealing at 55°C for 1 min, and polymerization at 70°C for 2 min. The PCR product was cloned into the Sma I site of pBluescribe, and plasmid DNA was sequenced as described above.
Initially, a 5' primer (PCR N3-5a), containing sequence upstream of the BALB/c Vp19 leader, and a 3' primer (PCR N3-3a), containing sequence close to the 3' end of the second exon, were used to obtain an amplified fragment including the first (leader) exon and most of the second exon; three independent clones containing this fragment were sequenced. Subsequently, another 5' primer (PCR N3-5b), containing sequence upstream of the leader, and another 3' primer (PCR N3-3d), containing sequence in the 3' untranslated region, were used to obtain a larger amplified fragment containing all of both V0 exons; one clone containing this fragment was sequenced. The sequences of the primers are as follows: PCR N3-5a: 5'-GAAGAATTCATTGTGTATGAGAAGGTAGCCTAAG-3; PCR N3-3a:5'-AGAGAATTC-ATCTGTTAGCTTGCTGGACTGGATC-3 ; PCR N3-5b: 5'-GAAGAATTCACCTTCAG-AGAAGACAGCTAGCTGA-3'; PCR N3-3d: 5'-AGAGAATTCGCTGATCAGCACTCT CTTGCTTCTT3.
Results
Design ofa Vg-speck Oligonucleotide. To design a Vo-specific oligonucleotide that could be used to screen cloned genomic DNA for new Vg genes, we examined the amino acid sequences encoded by the known VS genes for amino acid stretches that are highly conserved. It was noted that 14 of the 19 V0 genes that had been identified by the beginning of this study encoded Tyr-Phe/Leu-Cys-Ala-Ser-Ser as the last six COOH-terminal amino acids (Fig. 1) . From an examination of the nucleotide sequence that encodes these six amino acids, we arrived at a fourfold degenerate 18-mer (CASS oligonucleotide) that is the inverse complement of the coding sequence ( 19 18 18 18 15 16 18 17 15 16 7 1
Vp gansa of cosmid clones spanning the VS locus (including a series of overlapping cosmids encompassing the 330-kb region containing 20 of the previously identified Vas genes, two overlapping cosmids containing V#2, and two contiguous cosmids containing C01, C#2, and Vg14) yielded six CASS oligonucleotide-positive restriction fragments (designated by the prefix N in Fig. 2 ) that did not contain one of the known VO genes. A detailed map showing restriction sites and cosmids has been previously published (6) .
Two of the CASS oligonucleotide-positive fragments, N8 and N9, are located in the 55-kb gap between Vs1 and Vs5.2 . Two other fragments, N3 and N1, are located upstream and downstream, respectively, of V017b.
Nucleotide and Predicted Amino Acid Sequences of the New Yo Genes. Two criteria that were used to assess whether a sequence is that of a Vs gene are the presence of heptamer-nonamer recombination signals downstream of the second exon and the presence, in the predicted amino acid sequence, of the six amino acids that are absolutely conserved in all Vg genes discovered to date .
The nucleotide sequences of putative Vo genes in the CASS oligonucleotidepositive fragments are shown in Fig. 3 , followed by a number. A detailed map showing the restriction sites and the cosmid clones spanning this region of the genome has been previously published (6) . Nl is a 1.5-kb Kpn I-Eco RI fragment contained within the 8-kb Barn HI fragment of cosmid D18. N2 is a 1.1-kb Barn HI fragment from cosmid D18. N3 is a 7-kb Kpn I fragment from cosmid B2, which has an insert that is almost the same as that of cosmid B47. N5 is a 6-kb Kpn I-Sal I fragment from cosmid B47. N8 is a 2.4-kb Kpn I fragment from cosmid B41. N9 is a 4-kb Kpn I-Bam HI fragment from cosmid C47. Nucleotide sequence of the putative new V0 genes in the six CASS oligonucleotidepositive restriction fragments. The putative new Vp genes are named after the restriction fragments in which they lie. Initial sequence was obtained using the CASS oligonucleotide as sequencing primer; additional sequence upstream, downstream, and on the opposite strand was obtained with oligonucleotide primers derived from the initial sequence. The various sequences were aligned by first aligning the nucleotides encoding the invariant amino acids, which are shown (boldfaced) above the nucleotide sequence. Nucleotides are numbered according to Patten et al. (23) , with position 1 beingthe first base of the codon specifying the first amino acid of the mature V0 polypeptide segment after cleavage of the leader peptide. The sequence that hybridized with theCASS oligonucleotide is boxed. Putative heptamer and nonamer recombination signals downstream of the protein-coding region are underlined and denoted by 7 and 9, respectively. Dashes within the sequence indicate gaps that have been introduced to maximize homology. Shown in the last line is the sequence of V018, a gene for which a partial nucleotide sequence has been previously published (16) . These sequence data have been submitted to the EMBL/GenBank Data Libraries under the accession numbers X16689-X16695.
positive genes contain heptamer and nonamer recombination signals downstream of the protein-coding sequence. The exception, VON1, has a heptamer-like sequence, CACAATC, somewhat farther downstream than the heptamer found in other V0 genes, but no nonamer-like sequence 23 by downstream. The transcriptional orientation ofall six new CASS oligonucleotide-positive genes is the same as that ofpreviously identified V0 genes in the contiguous 330-kb genomic region screened .
The Amino acid sequences (Fig. 4) predicted by the nucleotide sequences were also examined to determine whether the encoded amino acids were characteristic of a V0 polypeptide segment. Three of the six new V,p genes (VSN3, VON8, and VpN9) have identifiable invariant amino acids in a single reading frame; thus, the amino acid sequence presented in Fig. 4 is that predicted by the nucleotide sequence of the single reading frame. The other three new CASS oligonucleotide-positive V0 The various amino acid sequences are aligned by the six amino acids that are invariant in the Vg genes identified to date ; these six invariant amino acids are shown (boldfaced) above the sequences. For those VA genes (VON3, VpN8, and V#N9) that have the invariant amino acids in a single reading frame, the amino acid sequence shown is that predicted by the nucleotide sequence of the single reading frame. For those V,6 genes (VONI, VON2, and V,gN5) that have the invariant amino acids in multiple reading frames, the sequence shown is a "best-fit" amino acid sequence ; the transition region between two reading frames, where a definite amino acid sequence cannot be deduced, is indicated by one or more plus signs. A dash within a sequence indicates a gap that has been introduced to optimize alignment. An asterisk indicates the position corresponding to a termination codon.
genes (VSNI, VSN2, and VsN5) have identifiable invariant amino acids in multiple reading frames, presumably due to nucleotide insertions and/or deletions; therefore, the amino acid sequence presented in Fig. 4 is a "best-fit" sequence, with a plus sign indicating the transition between two reading frames, where a specific amino acid sequence cannot be deduced. VSN1 and VON5 contain duplicated nucleotide stretches that disrupt the reading frame. The duplication in VsN1 includes the proline residue at position 8 that is absolutely conserved in all previously reported VS genes; in addition, VSN1 is missing one of the two invariant cysteine residues . The duplication in VON5 results in a duplication of the conserved tryptophan and tyrosine residues at positions 36 and 37 ; VON5 is also missing one of the two invariant cysteines and contains at least six termination codons . VRN8 contains three termination codons and is missing the conserved tryptophan residue at position 36 . VsN2, which contains at least two termination codons, is identical to a pseudogene, Vp3 .30, which had been identified earlier in our laboratory by crosshybridization with a V,g3 probe.
Two of the new oligonucleotide-positive genes, VsN3 and VON9, have open reading frames . VON9, however, contains neither of the conserved cysteine residues that are presumably involved in the intrachain disulfide bond . Thus, on the basis of sequence alone, five of the six new CASS oligonucleotide-positive genes cannot encode functional Vg polypeptide segments and are presumably pseudogenes. On the other hand, the open reading frame of VON3 encodes all six of the amino acids that are invariant in the previously reported V,0 genes; this potentially functional gene we call Vs19 .
Expression of Vs19. Because it had an open reading frame that encoded all six of the amino acids absolutely conserved in functional VS genes, and because it had heptamer-nonamer recombination signals downstream of the protein-coding region, V019 was potentially a functional gene and was therefore further characterized. To determine whether V019 is expressed, we performed RNase protection experiments using total cellular RNA and an RNA probe encompassing both exons of V019 (in- cluding sequence upstream of the leader exon) and the intervening intron . These experiments showed that V#19 was not transcribed in the thymus of BALB/c mice, the strain from which it was identified, but was transcribed in SJL thymus (Fig.  5 A) . SJL is a Va haplotype strain, in which a large deletion has eliminated 10 contiguous V,# gene segments, and in which nondeleted V,# genes might be compensatorily expressed at increased frequency. RNase protection analysis of RNA from another Vs haplotype (nondeletion) strain (C57BL/6) and from three other Vs haplotype strains (SWR, C57BR, and C57L) confirms the pattern ofexpression found RNase protection analysis of Vp19 (VpN3). (A) Autoradiograb ph of a gel from RNase protection assays using a Vp19 probe against RNA samples from two Vp haplotype strains and from four VS haplotype strains of mice . 50 wg of total cellular RNA was used in each assay. Details about the antisense RNA probe are given in Materials and Methods. As a negative control, the VS19 probe was assayed against yeast tRNA . The protected fragments are indicated by arrows labeled with V (for the Vp second exon) and L (for the leader exon and 5' flanking sequences). P indicates alane in which only RNA probe is loaded . s, spleen ; t, thymus . (B) Level of expression of Vp19 compared with that of Vpl6. As in A, 50 jug of total cellular RNA was used in each assay. Details about the Vp19 and Vp16 antisense RNA probes are given in Materials and Methods. The protected fragments, corresponding to the Vp second exons, are indicated by arrows on the right side of each panel. The sizes, in nucleotides, of selected fragments of an Msp I digest of pBR322 are shown on the left side ofeach panel. P, probe only; s, spleen ; t, thymus. (C) Comparison of Vp19 leader sequences from BALB/c and from SJL. ATG (initiation) codons, out-of-frame in BALB/c and in-frame in SJL, are underlined . The single-base insertion in the SJL sequence that results in an in-frame ATG upstream is indicated by an arrow. The lowercase letters at the 3' end of the sequence are the nucleotides at the 5' end of the intron between the first (leader) and second Vg exons.
in BALB/c and SJL; that is, absent (or undetectably low) expression in Vb haplotype strains and low-level expression in Vs haplotype strains (Fig. 5 A) . Comparison with Vp16, a Vp gene expressed in ti5% of Co-containing clones from an SJL thymus cDNA library (M. C. Louie, unpublished data) shows that the level of expression of V019 in SJL thymus is low, considerably less than that ofV016 (Fig. 5 B) .
RNase protection analysis of RNA from thymus of Va haplotype mice also reveals a protected fragment of -80 nucleotides (Fig. 5 A) , consistent with protection ofthe portion of the RNA probe corresponding to the leader exon and the adjacent upstream sequence of BALB/c Vp19b. Thus, in the Va haplotype strains of mice, a leader sequence that is identical to, or nearly identical to, the BALB/c Vp19b leader is transcribed.
To investigate whether a difference in the sequences of the Vp19 genes from V0 and Vb haplotype mouse strains may account for the difference in expression of the gene, we cloned the Vp19 gene from SJL genomic DNA by the PCR method, using oligonucleotide primers corresponding to sequences upstream of the BALB/c Vp19 leader sequence and within or downstream of the BALB/c Vp19 second exon . Comparison of the nucleotide sequences of the Vp19 genes from BALB/c and from SJL revealed that the exon sequences are identical, except for a single-base insertion in the leader exon of Vp19 from SJL, shifting the reading frame so that there is no longer an in-frame termination codon downstream ofan out-of-frame initiation codon, as was found in the leader exon of Vp19 from BALB/c, thereby resulting in a leader exon encoding 19 amino acids (Fig. 5 C) . Thus, in SJL, Vp19 is a functional gene.
Southern Blot Analysis of Vp19. Southern analysis of genomic DNA from BALB/c and from SJL showed RFLP at the Vp19 locus for five different restriction endonucleases (Fig. 6) . Similarly, the VpNl locus in BALB/c and in SJL showed RFLP for Eco RI, Hind III, and Bgl II (data not shown) . Genomic DNA prepared from the tails of mice of the six strains used in the RNase protection experiments (Fig .  5 A) and hybridized with the Vp19 second exon probe showed two-allele RFLP for FIGURE 6 . Southern blot analysis of total genomic DNA from BALB/c and from SJL . 15 Rg of high molecular weight DNA prepared from BALB/c or SJL liver was digested with the restriction enzymes indicated, and the DNA was separated on a 0 .7% agarose gel. The dried and denatured gel was hybridized with a 32 P-labeled Vs19 (VpN3) probe ; hybridization and wash conditions are given in Materials and Methods. Size markers, in kilobases, are shown at the left . B, BALB/c; S, SJL . both Kpn I (7 kb in the ,,,,b haplotype mice; 9 kb in the Vs haplotype mice) and Eco RI (2 .1 kb in the Vs haplotype mice ; 4.3 kb in the V0 haplotype mice) (data not shown) . A map of this genomic region is shown in Fig. 7 .
Discussion In this paper, we report the nucleotide and amino acid sequences of six new VO genes that were isolated by a novel method in which cloned genomic DNA is probed with a fourfold degenerate oligonucleotide that is complementary to the nucleotide sequence encoding six amino acids that are present at the COON terminal of approximately three fourths of the known VS polypeptide segments. Probing genomic DNA circumvents the difficulty of cloning genes that are expressed at very low frequency in a cDNA library. Since only about three fourths of the previously identified functional VS genes encode a polypeptide segment with Tyr-Phe/Leu-Cys-Ala-SerSer at the COOH-terminal end, we might expect, by extrapolation, that probing with the CASS oligonucleotide would fail to identify about one fourth of the yetunidentified V0 genes.
Five of the six CASS oligonucleotide-positive genes are pseudogenes, based on the presence of termination codons within the coding region or the absence of absolutely conserved amino acids, especially one or both of the cysteine residues that form the intrachain disulfide bond. Several of the new genes contain obvious frameshifts, suggesting the insertion or deletion ofone or more nucleotides. Nevertheless, based on the presence of other absolutely conserved amino acids and on the presence of heptamer and nonamer recombination signal sequences downstream of the protein-coding sequence, the newly identified genes are clearly recognizable as V0 gene segments .
Because only two ofthe first 22 V0 genes were pseudogenes, it was concluded that V0 pseudogenes are relatively rare. In contrast, the frequency of pseudogenes among Ig V genes is^+30% (24) . Here, however, we report the discovery of six new V0 pseudogenes, indicating that V0 pseudogenes are much more abundant than previously thought. An examination ofthe nucleotide sequences of these six pseudogenes reveals that the present nucleotide sequences can be derived from sequences encoding all six of the amino acids that are absolutely conserved among known VS gene segments by simple (often single-nucleotide) substitutions, insertions, or deletions. The pseudogenes that have been identified to date fall into two classes: pseudogenes (such as V#17b and V019b) with point mutations, and pseudogenes with more extensive mutations involving multiple regions of the coding sequences. The observation that all six ofthe new CASS oligonucleotide-positive V,6 genes in BALB/c are pseudogenes is more consistent with the hypothesis that the functional Ve repertoire is small and that most of the functional V0 genes have already been cloned than with the notion that the functional V0 repertoire is large, with many VS genes used infrequently.
Two of the new pseudogenes, VsN1 and VsN2 (Vg3 .30), are located in the relatively crowded genomic region bounded by VS15 and V03 .1, where two functional V,0 gene segments and four Vg pseudogenes are located within 39 kb of DNA (Fig .  7) . Further analysis of the nucleotide sequences (Fig. 3) reveals that these clustered genes are highly homologous . Not unexpectedly, the second and third members of the V03 subfamily (Vp17b and V03.30) are both 74% identical, at the nucleotide level, to Vp3 .1 . VONI is slightly less homologous (66-68% identical at the nucleotide level) to the three members of the V03 subfamily. V#19b is even less homologous (64-65% identical at the nucleotide level) to the V03 subfamily members and only 57% identical to VON1 . The extensive homology among these genes makes possible the process of recombination by homologous but unequal crossing over. Though the molecular mechanism and the specific sequence requirements of the recombination process are largely unknown, the extensive RFLP noted for V019 and VONI (this paper), and for V017 (15) , supports the notion that this region of highly homologous pseudogenes is the site of an increased rate of recombination. Interestingly, a newly described Vs deletion has its 3' boundary in this region (25) .
The RFLP at the V019 locus in the Vs and Vb haplotype mouse strains is analogous to that previously reported for V017 (15) . In keeping with the nomenclature established with VR17 (3, 15), we call V019a the allele that is present in Vq haplotype mouse strains and V019b the allele that is present in Vb haplotype strains.
RNase protection experiments reveal that a leader sequence identical to, or nearly identical to, the leader sequence from BALB/c, a Vb haplotype strain, is indeed transcribed (and presumably correctly spliced to a V019a second exon) in the Vahaplotype mice . Thus, the expression of V019a does not appear to involve alternative splicing of the transcripts from the second exon of V019a and from the intact leader exon of another Vp gene, as has been reported with the alternative splicing of the transcripts from the second exon of V08.2 and from the leader exon of VS5.1, a gene located -2 .5 kb upstream of V08.2 (2) .
It has been shown that T lymphocytes expressing Vp17a are clonally eliminated in mouse strains, such as C57BR, that express an I-E class II MHC molecule (5, 14, 15) . New gene V#19 was expressed in all four V' haplotype strains examined and not expressed in both Vs haplotype strains examined. By analogy, if Vs19a-carrying strains that do not express V#19a can be found, one might investigate whether VS19a is clonally eliminated because of reactivity to a self-antigen expressed in these strains.
Summary
By screening previously isolated genomic clones spanning the mouse TCR VS locus with Vo-specific oligonucleotides, we have isolated one new functional VS gene and six V0 pseudogenes. Because this method of identifying new genes does not depend on expression levels, we conclude that most, if not all, VAS genes in the mouse have been identified . The newly identified pseudogenes increase the frequency of mouse TCR Vp pseudogenes to 28%, a frequency similar to that estimated for mouse Ig V pseudogenes (24) .
Three of the newly discovered pseudogenes are clustered in a region around another pseudogene (Vo17b). The extensive DNA diversity, as reflected in both the nucleotide sequence and the RFLP, indicates that this genomic region is a possible hotspot of recombination .
The new functional gene, Vp19a, is expressed at very low levels, which explains why it has not been isolated earlier. Vs19 shows expression patterns that correlate with the previously described V~and Vs haplotypes.
